Showing papers by "Novartis Foundation published in 2011"

PDF

Open Access

Journal Article•DOI•

Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor

[...]

Hans Skvara¹, Frank Kalthoff², Josef G. Meingassner², Barbara Wolff-Winiski², Heinrich Aschauer², Joseph Kelleher², Xu Wu³, Shifeng Pan³, Lesanka Mickel¹, Christopher Schuster¹, Georg Stary¹, Ahmad Jalili¹, Olivier J. David², Corinne Emotte², Ana Antunes², Kristine Rose², Jeremy Decker², Ilene Carlson², Humphrey Gardner², Anton Stuetz², Arthur P. Bertolino², Georg Stingl¹, Menno A. De Rie² - Show less +19 more•Institutions (3)

Medical University of Vienna¹, Novartis², Novartis Foundation³

01 Aug 2011-Journal of Investigative Dermatology

TL;DR: Treatment with 0.75% LDE225 cream in NBCCS patients was very well tolerated and caused BCC regression, thus potentially offering an attractive therapeutic alternative to currently available therapies for this indication.

...read moreread less

143 citations